Patients commonly report 2 or more gastrointestinal symptoms after pancreatectomy, especially early in the first year after surgery.
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback